1
A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:December 2, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Multiple MyelomaLast Updated:December 2, 2019Unknown status
Condition(s):Multiple MyelomaLast Updated:June 2, 2020Unknown status
Condition(s):CAR-T Cell TherapyLast Updated:May 15, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.